These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37289567)

  • 1. Recent Advances of Emerging Spleen-Targeting Nanovaccines for Immunotherapy.
    He X; Wang J; Tang Y; Chiang ST; Han T; Chen Q; Qian C; Shen X; Li R; Ai X
    Adv Healthc Mater; 2023 Sep; 12(23):e2300351. PubMed ID: 37289567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node-targeting nanovaccines for cancer immunotherapy.
    Wang Q; Wang Z; Sun X; Jiang Q; Sun B; He Z; Zhang S; Luo C; Sun J
    J Control Release; 2022 Nov; 351():102-122. PubMed ID: 36115556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobiomaterial-based vaccination immunotherapy of cancer.
    Chen F; Wang Y; Gao J; Saeed M; Li T; Wang W; Yu H
    Biomaterials; 2021 Mar; 270():120709. PubMed ID: 33581608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-adjuvanting cancer nanovaccines.
    Liao Z; Huang J; Lo PC; Lovell JF; Jin H; Yang K
    J Nanobiotechnology; 2022 Jul; 20(1):345. PubMed ID: 35883176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
    Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
    Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Cancer Nanovaccines: Harnessing Nanotechnology for Broadening Cancer Immune Response.
    Wang QT; Liu YX; Wang J; Wang H
    ChemMedChem; 2023 Jul; 18(13):e202200673. PubMed ID: 37088719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanovaccines: An effective therapeutic approach for cancer therapy.
    Gurunathan S; Thangaraj P; Wang L; Cao Q; Kim JH
    Biomed Pharmacother; 2024 Jan; 170():115992. PubMed ID: 38070247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen Self-Presented Personalized Nanovaccines Boost the Immunotherapy of Highly Invasive and Metastatic Tumors.
    Wang T; Han M; Han Y; Jiang Z; Zheng Q; Zhang H; Li Z
    ACS Nano; 2024 Feb; 18(8):6333-6347. PubMed ID: 38349234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses.
    Yin Q; Wang Y; Xiang Y; Xu F
    Hum Vaccin Immunother; 2022 Nov; 18(6):2119020. PubMed ID: 36170662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy.
    He A; Li X; Dai Z; Li Q; Zhang Y; Ding M; Wen ZF; Mou Y; Dong H
    J Nanobiotechnology; 2023 Jul; 21(1):236. PubMed ID: 37482608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy.
    Li R; Hao Y; Pan W; Wang W; Min Y
    Acta Biomater; 2023 Nov; 171():482-494. PubMed ID: 37708924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy and Prevention of Cancer by Nanovaccines Loaded with Whole-Cell Components of Tumor Tissues or Cells.
    Ma L; Diao L; Peng Z; Jia Y; Xie H; Li B; Ma J; Zhang M; Cheng L; Ding D; Zhang X; Chen H; Mo F; Jiang H; Xu G; Meng F; Zhong Z; Liu M
    Adv Mater; 2021 Oct; 33(43):e2104849. PubMed ID: 34536044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanovaccines with cell-derived components for cancer immunotherapy.
    Meng Z; Zhang Y; Zhou X; Ji J; Liu Z
    Adv Drug Deliv Rev; 2022 Mar; 182():114107. PubMed ID: 34995678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanovaccines for cancer immunotherapy.
    Zhang Y; Lin S; Wang XY; Zhu G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Sep; 11(5):e1559. PubMed ID: 31172659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy.
    Mao L; Ma P; Luo X; Cheng H; Wang Z; Ye E; Loh XJ; Wu YL; Li Z
    ACS Nano; 2023 Jun; 17(11):9826-9849. PubMed ID: 37207347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance.
    Xu Z; Zhou H; Li T; Yi Q; Thakur A; Zhang K; Ma X; Qin JJ; Yan Y
    Drug Resist Updat; 2024 Jul; 75():101098. PubMed ID: 38833804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions.
    Li Y; Li S; Jiang Z; Tan K; Meng Y; Zhang D; Ma X
    J Nanobiotechnology; 2023 Jul; 21(1):212. PubMed ID: 37415161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologically Self-Assembled Tumor Cell-Derived Cancer Nanovaccines as an All-in-One Platform for Cancer Immunotherapy.
    Liang K; Sun Y; Xie L; Liu Y; You Y; Xu J; Ma F; Huang Y; Song Q; Xiao W; Huang J; Gao X; Chen J
    ACS Nano; 2024 Feb; 18(8):6702-6717. PubMed ID: 38359389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immunomodulatory Zinc-Alum/Ovalbumin Nanovaccine Boosts Cancer Metalloimmunotherapy Through Erythrocyte-Assisted Cascade Immune Activation.
    Zhao J; Zhang L; Li P; Liu S; Yu S; Chen Z; Zhu M; Xie S; Ling D; Li F
    Adv Sci (Weinh); 2024 Feb; 11(6):e2307389. PubMed ID: 38064201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.